当前化疗模式在软组织肉瘤中的衰落和衰落
John Rieth1, Varun Monga2, Mohammed Milhem1
1Holden Comprehensive Cancer Center, University of Iowa Health Care, Iowa City, IA 52242, USA.
Cancers
|April 14, 2025
概括
传统化疗对软组织肉瘤,一种典型的终端诊断,具有有限的益处. 进一步研究新型疗法,特别是新辅助疗法,对于改善患者的治疗结果至关重要.
科学领域:
- 在瘤学瘤学.
- 医学研究 医学研究
背景情况:
- 软组织肉瘤仍然是许多患者的终端诊断,即使使用常规细胞毒性化疗.
- 现有的化疗剂在软组织肉瘤的整体存活率上只显示了微不足道的改善.
研究的目的:
- 审查当前和新型化疗剂在治疗软组织肉瘤中的疗效.
- 确定未来研究领域,特别是新辅助药临床试验.
主要方法:
- 进行了全面的文献审查.
- 总结了相关辅助剂/新辅助剂和转移性疾病的临床试验.
主要成果:
- 在辅助剂/新辅助剂环境下进行的化疗对软组织肉瘤的益处提供了极少的证据.
- 新型化疗剂在转移性软组织肉瘤试验中显示出有限的长期疗效.
结论:
- 化疗是软组织肉瘤的不充分治疗方法,需要开发新型疗法.
- 新辅助剂环境为研究软组织肉瘤的创新治疗提供了有前途的机会.
相关概念视频
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Drugs that Stabilize Microtubules
1.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
1.9K


